



method for the analysis of ibandronate in
drug formulations and human urine
A simple, rapid and sensitive CE method coupled with electrochemiluminescence (ECL)
detection for direct analysis of ibandronate (IBAN) has been developed. Using a buffer
solution of 20 mM sodium phosphate (pH 9.0) and a voltage of 13.5 kV, separation of
IBAN in a 30-cm length capillary was achieved in 3 min. ECL detection was performed
with an indium tin oxide working electrode bias at 1.6 V (versus a Pt wire reference) in a
200-mM sodium phosphate buffer (pH 8.0) containing 3.5 mM Ru(bpy)3
21 (where
bpy 5 2,20-bipyridyl). Derivatization of IBAN prior to CE-ECL analysis was not needed.
Linear correlation (r 5 0.9992, n 5 7) between ECL intensity and analyte concentration
was obtained in the range of 0.25–50 mM IBAN. The LOD of IBAN in water was 0.08 mM.
The developed method was applied to the analysis of IBAN in a drug formulation and
human urine sample. SPE using magnetic Fe3O4@Al2O3 nanoparticles as the extraction
phase was employed to pretreat the urine sample before CE-ECL analysis. The linear
range was 0.2–12.0 mM IBAN in human urine (r 5 0.9974, n 5 6). The LOD of IBAN in
urine was 0.06 mM. Total analysis time including sample preparation was o1 h.
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pylidene]bisphosphonic acid monosodium; IBAN) (Fig. 1), a
relatively new nitrogen-containing bisphosphonate drug, is a
third-generation bisphosphonate for the treatment of bone
disease such as malignant hypercalcemia and postmenopau-
sal osteoporosis [1, 2]. Its once-monthly oral and quarterly
intravenous (i.v.) dosage regimens have the potential to
improve treatment adherence and persistence, and hence
clinical outcomes, compared with other frequently adminis-
tered oral bisphosphonates. Like other bisphosphonates,
IBAN inhibits osteoclast-mediated bone resorption. Due to
the stability of the P-C-P backbone and their polar nature,
IBAN does not undergo metabolic biotransformation follow-
ing oral administration and i.v. injection. It has been reported
that, in a mass balance study, nearly the entire oral IBAN
dose was excreted unchanged in the feces, and the majority of
i.v. IBAN was excreted unchanged in the urine within 24 h
[3]. For comprehensive studies of the pharmacology and
pharmacodynamic effects of IBAN in biological matrices, a
simple, sensitive and accurate assay is generally required.
Analysis of IBAN represents a challenge because of its
high polarity and low volatility. Furthermore, IBAN posses-
ses no chromophore or fluorophore, and its tertiary amine
characteristic renders derivatization difficult. Analytical
methods for IBAN reported to date are therefore limited. A
highly sensitive GC-MS assay for IBAN in serum/plasma
and urine was first described by Endele et al. [4]. The
quantification limits could reach low ng/mL level. However,
sample preparation was lengthy and tedious. Besides, in
order to lower IBAN’s polarity and enhance its volatility,
derivatization into methyl ester prior to GC separation was
required. A simple, non-derivatization detection method,
evaporative light-scattering detection (ELSD), coupled with
ion-pair HPLC analysis of IBAN was reported by Jiang and
Xie [5]. The main drawback of this method is its relatively
high LOD of IBAN (176 mg/mL). A post-column photo-
chemical derivatization followed by sensitive fluorometric
detection for HPLC determination of several bisphosphonate
drugs including IBAN in human urine has been reported by
Pérez-Ruiz et al. [6]. Detection was based on their oxidation
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photolysis followed by post-column reaction with molybdate
to yield phosphomolybdate. This subsequently reacted with
thiamine to generate thiochrome and, finally, the fluores-
cence of thiochrome was measured. This detection strategy is
in the nature of indirect detection mode. The LOD of IBAN
was 72 nM (23 ng/mL). A high-throughput HPLC-MS/MS
method for determining IBAN in human plasma has been
developed by Tarcomnicu et al. [7]. Liquid–liquid extraction
and methylation derivatization were used in sample
preparation. The LOQ was 0.2 ng/mL. Recently, a simple ion
chromatography (IC) method for the simultaneous deter-
mination of IBAN drug and its impurities has been reported
by Narendra Kumar et al. [8]. The LOD of IBAN was 38 mg/
mL. ELISA, the most sensitive method for IBAN to date with
a LOD at pg/mL level, also has been reported [4], but its
reagents were not readily available.
CE has been a popular technique for drug analysis
because of its high efficiency and versatility, very low sample
and reagent consumption, low cost and minimization of
environmental pollution. However, to our knowledge, there
has been no CE method reported for the analysis of IBAN
yet, which might be attributed to the lack of sensitive
detection method for IBAN. There was a report on the
use of CE-indirect UV detection for analyzing IBAN-
related impurities, i.e. phosphyte and phosphate, but
IBAN itself was not determined [9]. In recent years,
tris(2,20-bipyridyl)ruthenium(II) (Ru(bpy)3
21)-based electro-
chemiluminescence (ECL) has become an important and
powerful detection method for CE due to its high sensitivity
and simple instrumental setup [10]. It is known that amines,
particularly tertiary amines, can be directly determined by
utilizing their ECL reaction with electrogenerated Ru(bpy)3
31
without the need of derivatization [11, 12]. Since IBAN
structurally belongs to a tertiary amine, we expect that it
should be feasible to analyze IBAN with the CE-ECL
method.
In this paper, we describe a simple, rapid and sensitive
CE method coupled with Ru(bpy)3
21-ECL detection for the
analysis of non-derivatized IBAN. The electrochemical and
ECL behavior of IBAN and the optimal CE separation and
ECL detection conditions were investigated. The applic-
ability of this method to the analysis of IBAN in drug
formulation and human urine was then examined. In order
to remove the interference from urine matrix and to enrich
the analyte, SPE using magnetic alumina-coated iron oxide
nanoparticles (Fe3O4@Al2O3 NPs) as the extraction phase
[13, 14] was employed to the pretreatment of urine sample.
Report on the use of magnetic SPE for the separation of
drugs from biological matrices has been scarce [13]. Appli-
cation of this technique to the extraction of phosphate-
bearing drugs has not been reported either. We believe this
is the first report on both direct CE-ECL analysis and
magnetic SPE with Fe3O4@Al2O3 NPs for IBAN.
2 Materials and methods
2.1 Apparatus
Cyclic voltammetry (CV) and ECL studies were performed
with a CHI model 635 electrochemical station (Austin, TX,
USA). A three-electrode cell with an indium tin oxide (ITO)
working electrode (Delta Technologies, Stillwater, MN,
USA), an Ag/AgCl/saturated KCl reference and a Pt wire
auxiliary electrode was used for electrochemical measure-
ments. Optical signals were captured using a Hamamatsu
R928 PMT (Hamamatsu City, Japan), positioned in front of
the ITO electrode and biased at 900 V.
The laboratory-assembled CE-ECL system was similar to
that described previously [15]. Separation capillaries (Poly-
micro Technologies, Phoenix, AZ, USA) were of 50 mm
id 360 mm od 30 cm length. Prior to use, the capillary
was flushed sequentially with 0.5 M NaOH (10 min), H2O
(10 min) and electrophoretic buffer (15 min). Following each
five injections, the capillary was rinsed with 0.1 M NaOH,
H2O and electrophoretic buffer for 5 min to maintain a
reproducible inner surface. An ITO electrode, situated at the
capillary outlet and biased at 1.6 V (versus a Pt-wire refer-
ence), was used for in situ generation of the active
Ru(bpy)3
31. Sample injection was carried out hydro-
dynamically for 20 s at 10 cm height.
2.2 Chemicals
IBAN sodium (Z97%) and tris(2,20-bipyridyl)ruthenium(II)
chloride (Ru(bpy)3Cl2, 98%) were purchased from Sigma-
Aldrich (Milwaukee, WI, USA). Sodium tripolyphosphate
(Na5P3O10) was obtained from Showa (Tokyo, Japan). Iron
oxide (Fe3O4, particle size 20–30 nm) and sodium silicate
were bought from Alfa Aesar (Ward Hill, MA, USA). All
other chemicals were of analytical-reagent grade. All
solutions were filtered through a 0.45-mm pore-size
membrane filter before use.
2.3 Urine sample preparation
The fresh human urine sample of a healthy female
volunteer was acquired from a student in the laboratory.
Prior to analysis, 1.0 mL urine was added with 50 mL of
0.1 M NaOH (as blank) or a standard solution of IBAN in
0.1 M NaOH (as sample) and 50 mL of 1.0 M EDTA. The















Figure 1. Molecular structure of ibandronate sodium.
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14 000 g for 20 min using a microcentrifuge (model 3740;
Kubota, Tokyo, Japan) coupled with Millipore’s Amicons
Ultra-0.5 centrifugal filter devices (nominal molecular
weight limit 3 kDa). The filtrate was then subjected to
magnetic SPE using Fe3O4@Al2O3 NPs as the solid phase.
Preparation of the Fe3O4@Al2O3 NPs has been described
previously [14]. In a 2.0-mL polypropylene vial, 1.0 mL of the
above filtrate was ultrasonically mixed with 1 mg of
Fe3O4@Al2O3 NPs for 5 min. The NPs that conjugated
with IBAN were then aggregated by an external magnet, and
the supernatant liquid was completely removed with a
micropipette. The NPs were ultrasonically washed with
0.5 mL of 150 mM phosphate buffer solution (pH 9.0) for
5 min, and the supernatant liquid was discarded. This
washing step was repeated twice more. Finally, IBAN on the
NPs was rinsed off with 10 mL of 20 mM Na5P3O10 solution
(pH 9.0). The eluate was directly injected into the CE-ECL
system for analysis. Due to the concern of possible
contamination to the next sample, the used NPs were
discarded without further cleaning.
3 Results and discussion
3.1 Electrochemical and ECL behavior of IBAN on an
ITO electrode
The electrochemical and Ru(bpy)3
21-based ECL behavior of
IBAN in aqueous solution was first studied using CV and an
ITO electrode in a three-electrode cell. Figure 2A illustrates
the cyclic voltammogram obtained in a 20-mM sodium
phosphate buffer at pH 8.0 (curve a; dotted line). This
background voltammogram is featureless in the potential
range scanned (0–1.6 V). With the addition of 5 mM
Ru(bpy)3
21, the well-known reversible Ru21/31 redox waves
appear at 1.1 V (curve b; thin line). In the presence of
0.15 mM IBAN, the anodic wave for Ru(bpy)3
21 oxidation at
1.1 V is significantly enhanced (curve c; thick line). The
catalytic current enhancement was found to be proportional
to the concentration of IBAN in the solution. The redox
waves of IBAN itself were not observed in the potential
range scanned. The corresponding ECL-potential curves
obtained during CV scan are illustrated in Fig. 2B. There is
no ECL emission in the background electrolyte (curve a in
inset). In the presence of 5 mM Ru(bpy)3
21, weak ECL
emission emerges following the oxidation of Ru(bpy)3
21 and
reaches a maximum at 1.4 V (curve b in inset). With the
addition of 0.15 mM IBAN, significant enhancement (100-
fold) of ECL emission results (curve c), which evidences the
electrocatalytic effect of IBAN on the Ru(bpy)3
21-based ECL.
Since IBAN is a tertiary amine, its electrochemical and ECL
behavior in the Ru(bpy)3
21 solution should be similar to that
of Ru(bpy)3
21/tripropylamine system [16], and the mechan-
ism of ECL reaction between Ru(bpy)3
21 and tertiary amine
has been well-known [11]. Judging from the above results,
Ru(bpy)3
21-based ECL can be utilized as a sensitive tool for
direct detection of IBAN.
3.2 Optimization of CE-ECL procedure
3.2.1 Effect of detection potential
In the present work, a simple two-electrode cell with an ITO
working electrode and a Pt wire pseudo-reference was used
as the ECL detector for CE. The optimal detection potential
was investigated by repeated injection of 10 mM IBAN
standard into CE while varying the applied ITO electrode
potential in the range 1.0–2.0 V. The ECL intensity started to
increase from 1.2 V with increasing detection potential and
reached a plateau at 1.6 V (data not shown). The optimal
detection potential for IBAN was therefore set at 1.6 V. This
potential correlates well with the ECL result shown in
curve c of Fig. 2B.
3.2.2 Effect of RuðbpyÞ213 concentration in the detec-
tion cell
The variation of ECL intensities on the concentrations of
Ru(bpy)3
21 in the range of 1–5 mM was examined next. As
Figure 2. (A) Cyclic voltammograms of 20 mM sodium phos-
phate, pH 8.0 (curve a), 5 mM Ru(bpy)3
21 in phosphate buffer
(curve b) and 0.15 mM IBAN in phosphate buffer containing 5 mM
Ru(bpy)3
21 (curve c). (B) Corresponding ECL-potential curves of
(A). Conditions: working electrode, ITO (0.25 cm2); reference
electrode, Ag/AgCl/saturated KCl; counter electrode, Pt wire;
potential scan rate, 50 mV/s; PMT voltage, 900 V.
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expected, the intensity of ECL emission increased with
increasing Ru(bpy)3
21 concentration in the detection cell, but
the background noise also increased with higher concentra-
tion of Ru(bpy)3
21. The S/N ratio of ECL began to deteriorate
after reaching the maximum at a Ru(bpy)3
21 concentration
of 3.5 mM. Therefore, 3.5 mM Ru(bpy)3
21 was chosen as the
optimum.
3.2.3 Effect of buffer pH
The effect of buffer pH on the CE of IBAN was examined in
the pH range of 7.5–10. Using 20 mM sodium phosphate as
the electrophoretic buffer, the optimal migration time and
peak shape were found at pH 9.0. It is known that ECL
intensity for the reaction of Ru(bpy)3
21 and tertiary amine is
pH-dependent, and the optimal range is about pH 7–8 [17].
In the present study, we found that the optimum pH for
ECL detection of IBAN was 8.0. Since the CE buffer (pH 9.0)
in capillary continuously flowed into the detection cell
during analysis, in order to offset the possible pH variation
in the detector caused by CE eluate, a 200-mM sodium
phosphate buffer at pH 8.0 was used in the ECL detection
cell. This buffer solution was replaced with fresh one every
4 h to keep the pH value constant.
3.2.4 Effect of injection time
In the present study, sample injection was performed
hydrodynamically by immersing the capillary inlet in the
sample solution at 10 cm height relative to the outlet of the
capillary for a fixed time period. The effect of injection time on
the ECL intensity of IBAN peak was examined in the range of
5–40 s. The ECL intensity increased with increasing injection
time. However, the efficiency, calculated as the number of
theoretical plates, N, decreased with lengthy injection time. An
injection time of 20 s was judged optimal, as a compromise
between detection sensitivity and CE efficiency.
Figure 3 illustrates a typical electropherogram of IBAN
obtained with ECL detection under the optimal experi-
mental conditions described above. Sharp and symmetric
peak could be observed. The number of theoretical plates, N,
calculated from N 5 5.55 (tR/wh/2)2, was 1.05 104.
Complete elution of IBAN was achieved in about 2.8 min
with a capillary of 30 cm length. There is an elution band
appeared at about 0.2 min in Fig. 3. Although this band
showed up in most of the electropherograms obtained in
this work, its cause is not clear at present. The small peak
emerged at 1.3 min is probably due to impure constituent in
the commercial IBAN chemical (labeled purity Z97%) used
for the preparation of standard solution.
3.3 Analytical performance characteristics
Calibration graph was constructed for IBAN in the
concentration range 0.25–50 mM. The linear regression
equation was y 5 2.14(70.17) 103x0.19(70.02) 103
(r 5 0.9992, n 5 7), where y is the peak area and x is the
concentration (mM) of IBAN. The LOD (S/N 5 3) and LOQ
(S/N 5 10) for IBAN in water were 0.08 and 0.25 mM,
respectively, calculated from the signal height (0.348 mV) of
0.25 mM IBAN and the mean noise level (0.035 mV) at
2.8 min on the electropherograms of blank solution.
The intra-day precision of the method was examined by
repeated injection of three standard IBAN solutions at low
(0.5 mM), medium (2.5 mM) and high (20 mM) concentrations
for five times on the same day. The inter-day precision was
studied by analyzing the three standard samples one time each
day for five consecutive days. The RSD values of the migration
time and the ECL peak area are summarized in Table 1. The
intra-day RSDs for migration time and peak area were o0.6
and 5.1%, respectively. The inter-day RSDs for migration time
and peak area were o0.8 and 7.3%, respectively.
4 Applications
4.1 Analysis of drug formulation
The applicability of the developed CE-ECL method was first
examined by analyzing an i.v. formulation of IBAN (Bonvivas)
Figure 3. Electropherogram of IBAN obtained with ECL detec-
tion. Conditions: capillary size, 50 mm id360 mm od 30 cm
length; anodic buffer, 20 mM sodium phosphate (pH 9.0);
cathodic buffer, 200 mM sodium phosphate (pH 8.0) containing
3.5 mM Ru(bpy)3
21; CE voltage, 13.5 kV; hydrodynamic injection,
20 s at 10 cm height; ITO potential, 1.6 V; PMT voltage, –900 V.
IBAN concentration: 1 mM.
Table 1. Intra-day and inter-day precisions of migration time
and peak area for IBAN at different concentrations
(n 5 5)
Concentration (mM) RSD (%)
Migration time Peak area
Intra-day Inter-day Intra-day Inter-day
0.5 0.5 0.7 5.1 7.3
2.5 0.6 0.7 3.9 5.8
20 0.4 0.8 3.1 4.4
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from Roche (Switzerland). Owing to its relatively simple matrix,
the only pretreatment performed was a 350-fold dilution with
the CE buffer. Figure 4 shows the typical electropherogram
obtained for IBAN in diluted Bonvivas. A single and sharp
peak was observed. Based on triplicate analyses, the IBAN
content in Bonvivas was found to be 1003775 mg/mL (n 5 3),
which agrees well with manufacturer’s certified value (3 mg
ibandronic acid per 3 mL solution for i.v. injection).
4.2 Analysis of human urine
In order to assess the applicability of the method for biological
or clinical analysis, IBAN-spiked human urine was used as the
test sample. Due to the complex matrix of human urine, direct
CE-ECL analysis of IBAN in urine was difficult. Tedious and
time-consuming pretreatment of biological materials was
always involved prior to IBAN analysis [4, 6, 7]. In this study,
we attempted to develop a simple SPE procedure for IBAN in
urine sample. SPE using magnetic Fe3O4@Al2O3 NPs has
been a popular technique for selective enrichment of
phosphate-bearing biomolecules, e.g. phosphopeptides and
phosphoproteins, from complex biological samples [18, 19].
We had also efficiently extracted a phosphate-bearing herbicide,
glyphosate, from aqueous samples with SPE using Fe3O4@A-
l2O3 NPs as the solid phase [14]. The high specificity is due to a
bidentate binding nature between the phosphate group and
metal oxide surface [20]. The paramagnetic properties of these
particles also allow an easy isolation of products in solution by
attracting them with the aid of an external magnetic field. In
addition, magnetic NPs possess large surface area which
facilitates SPE. Since IBAN is a bisphosphonate compound, a
specific interaction between IBAN and Fe3O4@Al2O3 NPs
should also exist. A magnetic SPE procedure for IBAN in urine
was therefore developed, as described in Section 2.3. This
procedure was modified from our previous tactics of extracting
the uniphosphonate herbicide, glyphosate, from aqueous
sample with Fe3O4@Al2O3 NPs [14]. Instead of using Na4P2O7
solution as the eluting agent, IBAN attached on the magnetic
NPs was rinsed off with Na5P3O10 solution. This modification
was necessary because P3O10
5– revealed a higher eluting strength
than P2O7
3- for IBAN. The optimal concentration of Na5P3O10
was found to be 20 mM. Figure 5(A) shows the typical
electropherogram of a urine sample spiked with 0.5 mM IBAN
and subjected to ultrafiltration only. Despite the selectivity of
Ru(bpy)3
21-ECL detection, large extraneous peaks appear in the
background, indicating that it is not possible to remove the
interfering components in urine matrix by a single ultrafiltra-
tion pretreatment. Accurate determination of IBAN signal size
would be difficult because the analyte peak situated very close
to the huge extraneous peaks. Furthermore, the stability of CE
capillary as well as the sensitivity of ITO electrode in the
detection cell deteriorated rapidly with consecutive injections of
urine sample, probably caused by fouling of the capillary wall
and electrode surface. The electropherogram of the same urine
sample subjected to ultrafiltration followed by SPE with
Fe3O4@Al2O3 NPs is illustrated in Fig. 5B. In comparison
with Fig. 5A, those large matrix peaks totally disappear and just
a single IBAN peak shows up. Besides, the peak size of IBAN
in Fig. 5B is significantly larger than that in Fig. 5A, which
evidences the efficiency and specificity of SPE with Fe3O4@A-
l2O3 NPs for IBAN. The slight spreading of peak shape and
longer migration time of IBAN observed in Fig. 5B, compared
with Figs 3 and 4, may be due to conductivity and/or pH
differences between injected analyte zone and CE background
electrolyte [21].
Calibration graph was constructed using IBAN-spiked
human urine in the concentration range of 0.2–12.0 mM.
The linear regression equation was y 5 11.43(70.67)
103x0.99(70.12) 103 (r 5 0.9974, n 5 6, where y is the
peak area and x is the IBAN concentration in mM). The LOD
and LOQ for IBAN in urine were 0.06 and 0.2 mM (19 and
64 ng/mL), respectively. As a comparison, Table 2 lists the
reported LOD and/or LOQ values of IBAN in various
sample matrices by different analytical methods. The LOD/
LOQ values obtained with the developed CE-ECL method
Figure 4. Electropherogram of an intravenous formulation of
IBAN (350-fold diluted Bonvivas). Conditions as in Fig. 3.
Time (min)


















Figure 5. Electropherograms of human urine sample containing
0.5 mM IBAN. (A) Sample pretreatment with ultrafiltration only.
(B) Sample pretreatment with ultrafiltration followed by SPE
using magnetic Fe3O4@Al2O3 NPs as the solid phase. Other
conditions as in Fig. 3.
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are more than three orders of magnitude lower than those of
HPLC-ELSD [5] and IC conductometry [8] methods, and are
similar to that of the technically complicated HPLC-photo-
chemical derivatization-fluorometric detection method [6].
Although GC-MS [4] and HPLC-MS/MS [7] methods could
provide lower ng/mL level LOQ for IBAN in biological
fluids, both analyte derivatization and high-cost instru-
mentation were required. ELISA is the most sensitive and
selective method for IBAN reported to date. However, its
specific reagent is not readily available.
The intra-day and inter-day precisions of the method
were evaluated using urine samples spiked with 0.5 and
5.0 mM IBAN. The intra-day RSDs (n 5 5) for 0.5 and 5 mM
IBAN were 7.7 and 4.6%, respectively. The inter-day RSDs
(n 5 5) for 0.5 and 5 mM IBAN were 9.4 and 6.1%, respec-
tively. Mean recoveries, calculated as the ratio of IBAN
concentration found to that originally spiked, for 0.5 and
5 mM IBAN were 102 and 97% (n 5 5), respectively. Total
analysis time for each urine sample including pretreatment,
SPE and CE-ECL was o1 h.
5 Concluding remarks
A simple, rapid and sensitive CE-ECL method for the analysis
of IBAN has been developed. Compared with most chromato-
graphic methods for IBAN reported to date, derivatization of
the analyte prior to CE-ECL analysis is not necessary. High-cost
instrumentation is also not required. The feasibility of efficient
and accurate determination of IBAN in drug formulation by
the new method was demonstrated. In couple with SPE
pretreatment using magnetic Fe3O4@Al2O3 NPs as solid
phase, the proposed method was successfully applied to the
determination of IBAN at sub-mM level in human urine. The
novel magnetic SPE procedure developed for IBAN in urine
sample was simpler and faster than other reported pretreat-
ment methods. Combining the selectivity of Ru(bpy)3
21-ECL
detection and the specificity of Fe3O4@Al2O3 NPs extraction,
this method seems particularly suitable for the analysis of
phosphate-containing amines in biological and environmental
materials. To our knowledge, this is the first report on the
development of both CE-ECL method and magnetic SPE
pretreatment for trace IBAN in biological sample. Research on
the development of CE-ECL method for other structurally
similar bisphosphonate drugs is in progress.
Financial support from the National Science Council of
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